Nuveen Asset Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $693K | Buy |
192,424
+11,571
| +6% | +$41.7K | ﹤0.01% | 2863 |
|
|
2024
Q3 | $1.03M | Sell |
180,853
-250,160
| -58% | -$1.43M | ﹤0.01% | 2748 |
|
|
2024
Q2 | $1.99M | Buy |
+431,013
| New | +$1.99M | ﹤0.01% | 2400 |
|
|
2023
Q2 | – | Sell |
-356,609
| Closed | -$1.12M | – | 3204 |
|
|
2023
Q1 | $1.12M | Sell |
356,609
-20,915
| -6% | -$65.7K | ﹤0.01% | 2571 |
|
|
2022
Q4 | $2.23M | Sell |
377,524
-24,360
| -6% | -$144K | ﹤0.01% | 2342 |
|
|
2022
Q3 | $3.52M | Sell |
401,884
-6,175
| -2% | -$54.1K | ﹤0.01% | 2101 |
|
|
2022
Q2 | $3.08M | Sell |
408,059
-12,395
| -3% | -$93.5K | ﹤0.01% | 2213 |
|
|
2022
Q1 | $9.77M | Buy |
420,454
+157,052
| +60% | +$3.65M | ﹤0.01% | 1654 |
|
|
2021
Q4 | $7.47M | Sell |
263,402
-43,934
| -14% | -$1.25M | ﹤0.01% | 1858 |
|
|
2021
Q3 | $15.4M | Buy |
307,336
+106,944
| +53% | +$5.34M | ﹤0.01% | 1462 |
|
|
2021
Q2 | $7.58M | Buy |
200,392
+97,078
| +94% | +$3.67M | ﹤0.01% | 2021 |
|
|
2021
Q1 | $3.82M | Buy |
103,314
+78,690
| +320% | +$2.91M | ﹤0.01% | 2300 |
|
|
2020
Q4 | $816K | Buy |
+24,624
| New | +$816K | ﹤0.01% | 2879 |
|